Life Sciences Cos. Faced 65% More Securities Suits In 2012
Securities fraud class actions against life sciences companies increased almost 65 percent in 2012, and firms may be forced to pay out larger settlements in the wake of the U.S. Supreme...To view the full article, register now.
Already a subscriber? Click here to view full article